folic acid has been researched along with Kidney, Polycystic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barui, AK; Mohieldin, AM; Nauli, SM; Pala, R; Zhou, J | 1 |
| Chung, EJ; Hallows, KR | 1 |
| Fens, MHAM; Hennink, WE; Kok, RJ; Leonhard, WN; Peters, DJM; Shi, H; Sijbrandi, NJ; Toraño, JS; van de Dikkenberg, JB; van Steenbergen, MJ | 1 |
| Chu, H; Felten, AE; Leamon, CP; Lu, YJ; Nelson, M; Parker, N; Reddy, JA; Shillingford, JM; Vaughn, JF; Vlahov, IR; Wang, EZ; Westrick, E; Xu, LC | 1 |
| Calvet, JP; Hou, X; Magenheimer, BS; Maser, RL | 1 |
| Grantham, JJ | 1 |
6 other study(ies) available for folic acid and Kidney, Polycystic
| Article | Year |
|---|---|
Folate conjugated nanomedicines for selective inhibition of mTOR signaling in polycystic kidneys at clinically relevant doses.
Topics: Animals; Folic Acid; Mice; Nanomedicine; Nanoparticles; Polycystic Kidney Diseases; Sirolimus; Tissue Distribution; TOR Serine-Threonine Kinases | 2023 |
"First do no harm": kidney drug targeting to avoid toxicity in ADPKD.
Topics: Animals; Drug Delivery Systems; Folic Acid; Kidney; Mice; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Sirolimus | 2018 |
Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys.
Topics: Antineoplastic Agents; Cell Line; Drug Liberation; Folic Acid; Humans; Imidazoles; Kidney Tubules; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Polycystic Kidney Diseases; Quinolines; TOR Serine-Threonine Kinases | 2019 |
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.
Topics: A549 Cells; Animals; Doxycycline; Fluorescein-5-isothiocyanate; Folate Receptor 1; Folic Acid; HeLa Cells; Humans; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Molecular Targeted Therapy; Neoplasms; Oligopeptides; Polycystic Kidney Diseases; Protein Kinase C; Tissue Distribution; Trityl Compounds; Xenograft Model Antitumor Assays | 2019 |
A mouse kidney- and liver-expressed cDNA having homology with a prokaryotic parathion hydrolase (phosphotriesterase)-encoding gene: abnormal expression in injured and polycystic kidneys.
Topics: Amino Acid Sequence; Animals; Aryldialkylphosphatase; Base Sequence; DNA Primers; DNA, Complementary; Esterases; Folic Acid; Gene Expression; Gene Library; Kidney; Liver; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Molecular Sequence Data; Organ Specificity; Polycystic Kidney Diseases; Polymerase Chain Reaction; Reference Values; RNA, Messenger; Sequence Homology, Amino Acid | 1996 |
Renal cell proliferation and the two faces of cyclic adenosine monophosphate.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Division; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Folic Acid; Kidney Tubules; Phosphodiesterase Inhibitors; Polycystic Kidney Diseases | 1997 |